On the 3rd July 2025, the Labour government published its 10-year health plan for the NHS, setting out its vision to transform how healthcare is delivered across England. For health tech innovators, this is not just a policy, it’s a game-changing opportunity. Our experts Will Rose and Jessica Sandercock outline the key details of the plan and its impact on Health Tech in the UK.
The Government has recently announced the renewal of the women’s health strategy. Katy Jacks and Jessica Sandercock discuss what this means for the FemTech sector.
Could recent headline-grabbing transactions signal a return of the large healthcare deal?
Celebrating the UK’s top privately-owned pharma services companies and analysing key sector trends
Watch our team discuss the key trends influencing deal activity and find out why the UK is a centre of excellence for the industry.
The pharmaceutical industry uniquely protected from the impacts of tariffs.
A report on the UK’s medical products sector in 2025, including the top 100 leading companies in the sector.
Our comprehensive report provides an overview of the care homes sector, outlining the challenges faced by operators as well as exploring the potential, now and in the future.
The healthcare market is still an attractive prospect for investors. Stay informed on the key deals in our M&A review.
Delays in registering a change of ownership are preventing the completion of M&A transactions in the sector.
A legacy of underfunding means that the pharmacy sector needs to ensure it has the right business model to stay future-fit.
Our experts outline the constant pressures care home operators have to juggle due to numerous challenges facing the sector
Stay informed on M&A activity in Spring 2024, including key deals and trends across the market, with our quarterly round-up.
The healthcare market is still an attractive prospect for investors. Stay informed on the key deals in our M&A review.
Our Healthcare and PE experts discuss why Healthcare is an attractive sector for private equity investment, the surge of tech-enablement, value creation strategies and future trends to watch out for in 2024.
The third quarter was another buoyant period for healthcare M&A. Stay informed on the key trends in our latest review.
